p53, the cellular gatekeeper for growth and division

Cell

Volumn 88, Issue 3, 1997, Pages 323-331

  Levine, Arnold J ^a  

^a PRINCETON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; PROTEIN P53; TRANSCRIPTION FACTOR;

ALLELE; ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; CARCINOGENESIS; CELL DIVISION; CELL GROWTH; DNA STRAND BREAKAGE; HUMAN; HUMAN TISSUE; MOUSE; NEPHROBLASTOMA; NONHUMAN; PRIORITY JOURNAL; PROTEIN DNA BINDING; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION; REVIEW; STRESS; TUMOR SUPPRESSOR GENE;

ANIMALIA; PYRONIA TITHONUS;

EID: 0030941458     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0092-8674(00)81871-1     Document Type: Review

References (55)

1. Aas, T., Borresen, A.-L., Geisler, S., Smith-Sorensen, B., Johnsen, H., Vargaug, J.E.,Akslen, L.A., and Lonning, P.E. (1996). Specific p53 mutations are associated with de novo resistance to doxorubicin in breast cancer patients. Nature Med. 2, 811-814.
2. Bond, J.A., Blaydes, J.P., Rowson, J., Haughton, M.F., Smith, J.R., Wynford-Thomas, D., and Wyllie, F.S. (1995). Mutant p53 rescues human diploid cells from senescence without inhibiting the induction of SKI1/WAF1. Cancer Res. 55, 2404-2409.
3. Brown, C.R., Doxsey, S.J., White, E., and Welch, W.J. (1994). Both viral (adenovirus E1 B) and cellular (hsp 70, p53) components interact with centrosomes. J. Cell. Physiol. 160, 47-60.
4. Buckbinder, L., Talbott, R., Valesco-Miguel, S., Takenaka, I., Faha, B., Seizinger, B.R., and Kley, N. (1995). Induction of the growth inhibitor IGF-binding protein 3 by p53. Nature 377, 646-649.
5. Caelles, C., Heimberg, A., and Karin, M. (1994). p53-dependent apoptosis in the absence of p53-target genes. Nature 370, 220-223.
6. Cho, Y., Gorina, S., Jeffrey, P.D., and Pavletich, N.P. (1994). Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mutations. Science 265, 346-355.
7. Cross, S.M., Sanchez, C.A., Morgan, C.A., Schimke, M.K., Ramel, S., Idzerda, R.L., Rasking,W.H., and Reid, B.J. (1995).A p53-dependent mouse spindle checkpoint. Science 267, 1353-1356.
8. Debbas, M., and White, E. (1993). Wild-type p53 mediates apoptosis by E1A which is inhibited by E1 B. Genes Dev. 7, 546-554.
9. Del Sal, G.D., Ruaro, E.M., Utrera, R., Cole, C.N., Levine, A.J., and Schneider, C. (1995). Gas1-induced growth suppression requires a transactivation-independent p53 function. Mol. Cell. Biol. 75, 7152-7160.
10. CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control. Cell 82, 675-684.
11. Dittmer, D., Pati, S., Zambetti, G., Chu, S., Teresky, A.K., Moore, M., Finlay, C., and Levine, A.J. (1993). p53 gain of function mutations. Nature Genet. 4, 42-46.
12. Donehower, L.A., Godley, L.A., Aldaz, C.M., Pyle, R., Shi, Y.-P., Pinkel, D., Gray, J., Bradley, A., Demina, D., andVarmus, H.E. (1995). Deficiency of p53 accelerates mamary tumorigenesis in Wnt-1 transgenic mice and promotes chromosomal instability. Genes Dev. 9, 882-895.
13. Donehower, L.A., Harvey, M., Slagle, B.L., McArthur, M.J., Montgomery, C.A., Jr., Butel, J.S., and Bradley, A. (1992). Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature (Lond.) 356, 215-221.
14. EL-Deiry, W.S.,Tokino, T., Velculescu, V.E., Levy, D.B., Parsons, R., Trent, J.M., Lin, D., Mercer, W.E., Kinzler, K.W., and Vogelstein, B. (1993). WAF1, a potential mediator of p53 tumor suppression. Cell 75, 817-825.
15. Friedlander, P., Haupt, Y., Prives, C., and Oren, M. (1996). A mutant p53 that discriminates between p53-responsive genes cannot induce apoptosis. Mol. Cell. Biol. 16, 4961-4971.
16. Fukasawa, K., Choi, T., Kuriyama, R., Rulong, S., and Vande Woude, G. F. (1996). Abnormal centrosome amplification in the absence of p53. Science 277, 1744-1747.
17. Goga, A., Liu, X., Hambuch, T.M., Senechal, K., Major, E., Berk, A.J., Witte, O.N., and Sawyers, C.L. (1995). p53-dependent growth suppression by the c-Abl nuclear tyrosine kinase. Oncogene 11, 791-799.
18. Graeber, A.J., Osmanian, C., Jack, T., Housman, D.E., Koch, C.J., Lowe, S.W., and Graccia, A.J. (1996). Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumors. Nature 379, 88-91.
19. Guidos, C.J., Williams, C.J., Grandal, I., Knowles, G., Huang, M.T.F., and Danska, J.S. (1996). V(D)J recombination activates a p53-dependent DNA damage checkpoint in scid lymphocyte precursors. Genes Dev. 70, 2038-2054.
20. Haupt, Y., Rowan, S., Shaulian, E., Vousden, K.,and Oren, M. (1995). Induction of apoptosis in HeLa cells by transactivation-deficient p53. Genes Dev. 9, 2170-2183.
21. Hollstein, M., Rice, K., Greenblatt, M.S., Soussi, T., Fuchs, R., Sorlie, T., Hovig, E., Smith-Sorensen, B., Montesano, R., and Harris, C.C. (1994). Database of p53 gene somatic mutations in human tumors and cell lines. Nucleic Acids Res. 22, 3551-3555.
22. Howes, K.A., Ransom, N., Papermaster, D.S., Lasudry, J.G. H., Albert, D.M., and Windle, J.J. (1994). Apoptosis or retinoblastoma: alternative fates of photoreceptors expressing the HPB-16 E7 gene in the presence or absence of p53. Genes Dev. 8, 1300-1310.
23. Hupp, T.R., and Lane, D.P. (1994). Allosteric activation of latent p53 tetramers. Curr. Biol. 4, 865-875.
24. Jayaraman, L., and Prives, C. (1995). Activation of p53 sequence-specific DNA binding by short single strands of DNA requires the p53 C-terminus. Cell 81, 1021-1029.
25. Jeffrey, P.D., Gorina, S.,and Pavletich, N.P. (1995). Crystal structure of the tetramerization domain of the p53 tumor suppressor at 1.7 angstroms. Science 267,1498-1502.
26. Johnson, P., Chung, S., and Benchimol, S. (1993). Growth suppression of Friend virus-transformed erythroleukemia cells by p53 protein is accompanied by hemoglobin production and is sensitive to erythropoietin. Mol. Cell. Biol. 13, 1456-1463.
27. Kastan, M.B., Zhan, Q., EL-Deiry, W.S., Carrier, F., Jacks, T., Walsh, W. V., Plunkett, B.S., Vogelstein, B., and Fornace, A.J., Jr. (1992). A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia. Cell 71, 587-597.
28. Kemp, C.J., Donehower, L.A., Bradley, A., and Balmain, A. (1993). Reduction of p53 gene dosage does not increase initiation or promotion by enhances malignant progression of chemically induced skin tumors. Cell 74, 813-822.
29. Ko, L.J., and Prives, C. (1996). p53: puzzle and paradigm. Genes Dev. 10, 1054-1072.
30. Kussie, P.H., Gorina, S., Marechal, V., Elenbaas, B., Moreau, J., Levine, A.J., and Pavletich, N.P. (1996). Crystal structure of the MDM2 oncoprotein bound to the transactivation domain of the p53 tumor suppressor. Science 274, 948-953.
31. Lee, S., Elenbaas, B., Levine, A.J., and Griffith, J. (1995). p53 and its 14kDa C-terminal domain recognize primary DNA damage in the form of insertion/deletion mismatches. Cell 81, 1013-1020.
32. Lin, J., Wu, X., Chen, J., Chang, A., and Levine, A.J. (1995). Functions of the p53 protein in growth regulation and tumor suppression. Cold Spring Harbor Symposia on Quantitative Biology LIX, 215-223.
33. Linke, S.P., Clarkin, K.C., DiLeonardo, A., Tsou, A., and Wahl, G.M. (1996). A reversible, p53-dependent GO/G1 cell cycle arrest induced by ribonucleotide depletion in the absence of detectable DNA damage. Genes Dev. 10, 934-947.
34. Livingstone, L.R., White, A., Sprouse, J., Livanos, E., Jacks, T., and Tlsty, T.D. (1992). Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53. Cell 70, 923-935.
35. Lowe, S.W., Ruley, H.E., Jacks, T., and Houseman, D.E. (1993a). p53-Dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell 74, 957-968.
36. Lowe, S.W., Schmitt, E.M., Smith, S.W., Osborne, B.A., and Jacks, T. (1993b). p53 is required for radiation induced apoptosis in mouse thymocytes. Nature 362, 847-849.
37. Lu, H., and Levine, A.J. (1995). Human TAF-31 is a transcriptional coactivator of the p53 protein. Proc. Natl. Acad. Sci. USA 92, 5154-5158.
38. Lutzker, S., and Levine, A.J. (1996). A functionally inactive p53 protein in embryonal carcinoma cells is activated by DNA damage or cellular differentiation. Nature Med. 2, 804-810.
39. Maheswaran, S., Englert, C., Bennett, P., Heinrich, G., and Haber, D. A. (1995). The Wt1 gene product stabilizes p53 and inhibits p53-mediated apoptosis. Genes Dev. 9, 2143-2156.
40. Miyashita, T., and Reed, J.C. (1995). Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 80, 293-299.
41. Montes de Oca Luna, R., Wagner, O., and Lozano, G. (1995). Rescue of early embryonic lethality in mdm2-deficient mice by deletion of p53. Nature 378, 203-206.
42. Nicol, C., Harrison, M., Laposa, G., Gimelshtein, I., and Wells, P. (1995). A teratologic suppressor role for p53 in benzo[a] pyrenetreated transgenic p53-deficient mice. Nature Genet. 10, 181-187.
43. Oliner, J.D., Kinzler, K.W., Meltzer, P.S., George, D., and Vogelstein, B. (1992). Amplification of a gene encoding a p53-associated protein in human sarcomas. Nature 358, 80-83.
44. Polyak, K., Waldman, T., He, T.-C., Kinzler, K.W., and Vogelstein, B. (1996). Genetic determinants of p53-induced apoptosis and growth arrest. Genes Dev. 10, 1945-1952.
45. Sabbatini, P., Lin, J., Levine, A.J., and White, E. (1995). Essential role for p53-mediated transcription in E1A-induced apoptosis. Genes Dev. 9, 2184-2192.
46. Sun, X.-F., Johannsson, O., Hakansson, S., Seilberg, G., Nordenskjold, B., Olsson, H., and Borg, A. (1996). A novel p53 germline alteration identified in a late onset breast cancer kindred. Oncogene 13, 407-411.
47. Symonds, H., Krall, L., Remington, L., Saenz-Robies, M., Lowe, S., Jacks, T., and Van Dyke, T. (1994). p53-Dependent apoptosis suppresses tumor growth and progression in vivo. Cell 78, 703-711.
48. Thut, C.J., Chen, J.L., Klemin, R., and Tjian, R. (1995). p53 transcriptional activation mediated by coactivators TAFII40 and TAFII60. Science 267, 100-104.
49. Waf1/cip1. Genes Dev. 8, 2817-2830.
50. Walker, K.K., and Levine, A.J. (1996). Identification of a novel p53 functional domain which is necessary for efficient growth suppression. Proc. Natl. Acad. Sci. USA 93, 15335-15340.
51. Wang, X.W., Yeh, H., Schaeffer, L., Roy, R., Moncollin, V., Egly, J.-M., Wang, Z., Friedberg, E.C., Evans, M.K., Taffe, B.G., et al. (1995). p53 modulation of TFIIH associated nulceotide excision repair activity. Nature Genet. 10, 188-195.
52. Williams, B.O., Remington, L., Albert, D.M., Mukai, S., Bronson, R.T., and Jacks, T. (1994). Cooperative tumorigenic effects of germline mutations in Rb and p53. Nature Genet. 7, 480-484.
53. Wu, X., and Levine, A.J. (1994). p53 and E2F-1 cooperate to mediate apoptosis. Proc. Natl. Acad. Sci. USA 91, 3602-3606.
54. Yonish-Rouach, E., Resnitzky, D., Lotem, J., Sachs, L., Kimchi, A., and Oren, M. (1991). Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6. Nature 352, 345-347.
55. Ziegler, A., Jonason, A.S., Leffell, D.J., Simon, J.A., Sharma, H.W., Kimmelman, J., Remington, L., Jacks, T., and Brash, D.E. (1994). Sunburn and p53 in the onset of skin cancer. Nature 372, 773-776.